Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.80
-0.02 (-0.29%)
At close: Sep 3, 2026, 4:00 PM EDT
6.81
+0.01 (0.15%)
After-hours: Sep 3, 2026, 4:10 PM EDT

Profound Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
250285225202223234
Market Cap Growth
86.24%26.48%11.58%-9.56%-4.57%-41.98%
Enterprise Value
218265206176178163
Last Close Price
6.807.877.518.4910.8911.23

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.1117.7121.1028.0633.4334.05
PB Ratio
5.024.293.736.474.302.90
P/TBV Ratio
5.034.303.756.574.353.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.4416.4419.2724.4326.5823.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.070.090.250.160.02
Net Debt / Equity Ratio
-0.62-0.83-0.82-0.59-0.74-0.82
Net Debt / EBITDA Ratio
0.891.351.550.661.332.22
Net Debt / FCF Ratio
0.851.432.120.811.482.94
Asset Turnover
0.340.220.190.130.090.07
Inventory Turnover
0.570.670.570.390.480.62
Quick Ratio
5.2611.029.445.2612.6316.50
Current Ratio
6.4612.5310.526.5814.8218.56
Return on Equity (ROE)
-73.53%-67.12%-60.70%-68.06%-43.23%-34.50%
Return on Assets (ROA)
-39.46%-34.91%-36.19%-33.05%-24.47%-19.79%
Return on Capital Employed (ROCE)
-66.40%-57.80%-51.90%-76.20%-49.10%-36.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.09%-14.93%-12.34%-14.02%-12.84%-13.12%
FCF Yield
-14.50%-13.46%-10.41%-11.19%-11.55%-9.57%
Buyback Yield / Dilution
-20.87%-22.08%-16.91%-1.69%-1.79%-18.33%
SEC Filings: 10-K · 10-Q